U.S. federal trademark · Serial No. 88624903 · Reg. No. 6128350
Medical dosimetry services in the field of radiopharmaceutical therapy for treating cancer, hyperthyroidism, or other metabolic or physiological conditions or diseases; medical dosimetry services for diagnostic radiopharmaceuticals for diagnosis or prognosis of metabolic, functional, or physiological conditions or diseases such as neoplasia or neurological, skeletal, respiratory, digestive, cardiovascular, endocrine, reproductive disorders; provide consulting services to developers of radiopharmaceuticals related to dosimetry, [ risk analysis ] and quantitative reconstruction related to dosimetry
Software as a service (SAAS) services featuring software tools for image analysis, [ risk analysis, ] quantitative reconstruction, dosimetry, and prediction of organ toxicity and therapeutic efficacy in the field of radiopharmaceutical therapy for use by medical and research laboratories
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.